Matea Dominkovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matea Dominkovic has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Kerry Hitos
Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
2 shared publications - Arthur J. Richardson
Department of Hepatobiliary, Pancreatic/Upper Gastrointestinal Surgery Westmead Hospital Westmead New South Wales Australia
1 shared publication - Edgardo Solis
Department of Surgery, Westmead Hospital, Sydney, New South Wales, Australia
1 shared publication - Evangeline Woodford
Department of Surgery, Westmead Hospital, Westmead, Australia
1 shared publication - Geoffrey Collins
Department of Colorectal Surgery, John Hunter Hospital, Newcastle, Australia
1 shared publication George Chen
1 shared publication
Latest Publications
- Open Access
- 16 September 2026
- Published by Springer Nature in World Journal of Emergency Surgery
Same-day discharge appendicectomy protocol (SDAP): implementation and outcomes from an Australian prospective study
- 16 September 2026
- Published by Springer Nature in World Journal of Emergency Surgery
Open AccessSame-day discharge appendicectomy protocol (SDAP): implementation and outcomes from an Australian prospective study
- Open Access
- 26 July 2026
- Published by Wiley in Anz Journal of Surgery
Clinical Relevance of the SOUND and INSEMA Trials in Women With Early Breast Cancer in Australia and New Zealand
Background: Axillary surgery in breast cancer has undergone progressive de‐escalation. The recent Sentinel Node versus Observation after Axillary Ultrasound (SOUND) and Intergroup Sentinel Mamma (INSEMA) trials have demonstrated that sentinel lymph node biopsy may be safely omitted in selected patients. This study aimed to evaluate the clinical relevance and applicability of the SOUND and INSEMA trial criteria within the Australian and New Zealand context. Methods: Prospectively maintained data from the BreastSurgANZ Quality Audit (BQA) was analysed. Patients with invasive breast cancer treated between 2019 and 2023 who met the inclusion criteria of the SOUND and INSEMA trials were identified. Results: A total of 69 122 patients were treated for invasive breast cancer over the five‐year study period, of whom 30 822 fulfilled the inclusion criteria of either the SOUND or INSEMA trials. Overall, 34.0% and 44.6% of patients with invasive breast cancer in Australia and New Zealand met the SOUND and INSEMA eligibility criteria, respectively. Tumour characteristics of BQA patients were more closely aligned with those reported in the SOUND trial than the INSEMA trial, although key differences in other clinicopathological features were observed. Conclusions: The SOUND and INSEMA trial criteria are applicable to over one‐third of patients with invasive breast cancer in Australia and New Zealand, supporting the potential relevance of axillary surgery de‐escalation in this population.
- 26 July 2026
- Published by Wiley in Anz Journal of Surgery
Open AccessClinical Relevance of the SOUND and INSEMA Trials in Women With Early Breast Cancer in Australia and New Zealand
Background: Axillary surgery in breast cancer has undergone progressive de‐escalation. The recent Sentinel Node versus Observation after Axillary Ultrasound (SOUND) and Intergroup Sentinel Mamma (INSEMA) trials have demonstrated that sentinel lymph node biopsy may be safely omitted in selected patients. This study aimed to evaluate the clinical relevance and applicability of the SOUND and INSEMA trial criteria within the Australian and New Zealand context. Methods: Prospectively maintained data from the BreastSurgANZ Quality Audit (BQA) was analysed. Patients with invasive breast cancer treated between 2019 and 2023 who met the inclusion criteria of the SOUND and INSEMA trials were identified. Results: A total of 69 122 patients were treated for invasive breast cancer over the five‐year study period, of whom 30 822 fulfilled the inclusion criteria of either the SOUND or INSEMA trials. Overall, 34.0% and 44.6% of patients with invasive breast cancer in Australia and New Zealand met the SOUND and INSEMA eligibility criteria, respectively. Tumour characteristics of BQA patients were more closely aligned with those reported in the SOUND trial than the INSEMA trial, although key differences in other clinicopathological features were observed. Conclusions: The SOUND and INSEMA trial criteria are applicable to over one‐third of patients with invasive breast cancer in Australia and New Zealand, supporting the potential relevance of axillary surgery de‐escalation in this population.
- Open Access
- 6 May 2026
- Vol. 2026 (5)
Appendicitis causing psoas and liver abscesses—a rare combination
We present the case of a young, otherwise healthy male, who presented with synchronous psoas and liver abscesses secondary to acute appendicitis. These are both rare occurrences in the setting of acute appendicitis, which can dramatically increase the case complexity and mortality risk. Their occurrence synchronously has not previously been reported. The patient was managed acutely with percutaneous drainage of the liver abscess and long course antibiotic therapy before undergoing interval appendicectomy with colonoscopy.
- 6 May 2026
- Vol. 2026 (5)
Open AccessAppendicitis causing psoas and liver abscesses—a rare combination
We present the case of a young, otherwise healthy male, who presented with synchronous psoas and liver abscesses secondary to acute appendicitis. These are both rare occurrences in the setting of acute appendicitis, which can dramatically increase the case complexity and mortality risk. Their occurrence synchronously has not previously been reported. The patient was managed acutely with percutaneous drainage of the liver abscess and long course antibiotic therapy before undergoing interval appendicectomy with colonoscopy.
- Open Access
- 31 May 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (6) , rjaf426
Case report and literature review of gallbladder paraganglioma in patient with inflammatory bowel disease
Primary paraganglioma of the gallbladder is an extremely rare pathology. Only 21 cases have been reported in the literature, and we present the first reported case of gallbladder paraganglioma in a patient with inflammatory bowel disease and primary sclerosing cholangitis. A 54-year-old lady with history of chronic right upper quadrant pain on a background of inflammatory bowel disease and primary sclerosing cholangitis underwent laparoscopic cholecystectomy due to gallbladder polyps and gallbladder wall irregularity on surveillance imaging. Her histopathology incidentally noted gallbladder paraganglioma. Due to their scarcity, there is no consensus on management and follow-up of gallbladder paraganglioma. All previously reported cases have been thus far benign and adequately treated with cholecystectomy, however, intra-abdominal extra-adrenal paragangliomas have malignant and metastatic potential hence we would advocate for surveillance.
- 31 May 2025
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2025 (6) , rjaf426
Open AccessCase report and literature review of gallbladder paraganglioma in patient with inflammatory bowel disease
Primary paraganglioma of the gallbladder is an extremely rare pathology. Only 21 cases have been reported in the literature, and we present the first reported case of gallbladder paraganglioma in a patient with inflammatory bowel disease and primary sclerosing cholangitis. A 54-year-old lady with history of chronic right upper quadrant pain on a background of inflammatory bowel disease and primary sclerosing cholangitis underwent laparoscopic cholecystectomy due to gallbladder polyps and gallbladder wall irregularity on surveillance imaging. Her histopathology incidentally noted gallbladder paraganglioma. Due to their scarcity, there is no consensus on management and follow-up of gallbladder paraganglioma. All previously reported cases have been thus far benign and adequately treated with cholecystectomy, however, intra-abdominal extra-adrenal paragangliomas have malignant and metastatic potential hence we would advocate for surveillance.